Pfizer PFE
NYSE PFE
$28.53 -0.20 (-0.70%)
At close: Sep 30, 2026 · 4:00 PM EDT

Pfizer (PFE) Non-Current Assets (2009 - 2026)

Updated

Pfizer (PFE) recorded Non-Current Assets of $159.77 billion in Q2 2026, down 1.6% from $162.39 billion a year earlier and down 3.3% from the prior quarter.

Analysis

Pfizer (PFE) Non-Current Assets (2009 - 2026) Analysis & Trends

At the end of FY2025, Pfizer reported Non-Current Assets of $3.3 billion, up 2.3% from FY2024.

  • Annual Non-Current Assets has a five-year compound annual growth rate of -0.5% (FY2020 to FY2025).
  • Across earlier years, Non-Current Assets came in at $3.22 billion in FY2024 (+7.1%), $3.01 billion in FY2023 (-0.2%), $3.01 billion in FY2022 (-15.4%) and $3.56 billion in FY2021 (+5.4%).
  • Quarterly Non-Current Assets has ranged from $3.01 billion in Q4 2023 to $178.68 billion in Q1 2024 over the past five years.
  • On a year-over-year basis, Non-Current Assets rose in three of the last seven quarters, with an average decline of 2.4%.
  • Peak year-over-year performance for Non-Current Assets in the last five years was growth of 22.4% in Q1 2024, against a decline of 15.4% in Q4 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at $165.18 billion (Q1 2026), $3.3 billion (Q4 2025) and $162.08 billion (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 141.29 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 101.45 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 125.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 94.68 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 87.87 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 60.68 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 35.42 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 159.77 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 14.88 Bn
10 Bristol Myers Squibb 127.55 Bn 78.82 Bn 9.25 Bn 59.06 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 28, 2026 159.77 Bn
Mar 29, 2026 165.18 Bn
Dec 31, 2025 3.30 Bn
Sep 28, 2025 162.08 Bn
Jun 29, 2025 162.39 Bn
Mar 30, 2025 162.17 Bn
Dec 31, 2024 3.22 Bn
Sep 29, 2024 176.25 Bn
Jun 30, 2024 178.37 Bn
Mar 31, 2024 178.68 Bn
Dec 31, 2023 3.01 Bn
Sep 30, 2023 36.95 Bn
Jul 2, 2023 146.82 Bn
Apr 2, 2023 145.92 Bn
Dec 31, 2022 3.01 Bn
Sep 30, 2022 35.20 Bn
Jul 3, 2022 127.82 Bn
Apr 3, 2022 129.58 Bn
Dec 31, 2021 3.56 Bn
Oct 3, 2021 39.45 Bn
API Access

Pfizer Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-assets&ticker=PFE&period=max&api_key=YOUR_API_KEY